These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8993398)

  • 1. Pancreatic beta-cell receptors and G proteins coupled to adenylyl cyclase.
    Marie JC; Rosselin G; Skoglund G
    Ann N Y Acad Sci; 1996 Dec; 805():122-31; discussion 132. PubMed ID: 8993398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon acts through its own receptors in the presence of functional glucagon-like peptide-1 receptors on hamster insulinoma.
    Marie JC; Boissard C; Skoglund G; Rosselin G; Breant B
    Endocrinology; 1996 Oct; 137(10):4108-14. PubMed ID: 8828464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
    Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
    Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory transducing systems in pancreatic islet cells.
    Emami S; Regnauld K; Ferrand N; Astesano A; Pessah M; Phan H; Boissard C; Garel JM; Rosselin G
    Ann N Y Acad Sci; 1998 Dec; 865():118-31. PubMed ID: 9928004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.
    Fehmann HC; Göke R; Göke B
    Mol Cell Endocrinol; 1992 May; 85(1-2):C39-44. PubMed ID: 1382025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GIP and GLP-1: multiplicity of regulator mechanisms for insulin secretion].
    Thorens B
    Journ Annu Diabetol Hotel Dieu; 2004; ():111-25. PubMed ID: 15259310
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.
    Li Y; Cao X; Li LX; Brubaker PL; Edlund H; Drucker DJ
    Diabetes; 2005 Feb; 54(2):482-91. PubMed ID: 15677506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
    Gefel D; Barg Y; Zimlichman R
    Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucagon-like peptides: a double-edged therapeutic sword?
    Perry T; Greig NH
    Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
    Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
    Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
    Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.
    Fehmann HC; Göke R; Göke B
    Endocr Rev; 1995 Jun; 16(3):390-410. PubMed ID: 7671853
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
    Ahrén B
    Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiology of GLP-1--lessons from glucoincretin receptor knockout mice.
    Thorens B
    Horm Metab Res; 2004; 36(11-12):766-70. PubMed ID: 15655706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.
    Wheeler MB; Lu M; Dillon JS; Leng XH; Chen C; Boyd AE
    Endocrinology; 1993 Jul; 133(1):57-62. PubMed ID: 8391428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
    Drucker DJ
    Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
    Holz GG
    Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incretin research in the development of new strategies of diabetes therapy].
    Göke B; Göke R; Fehmann HC; Arnold R
    Internist (Berl); 1995 Apr; 36(4):343-9. PubMed ID: 7775082
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy.
    De León DD; Deng S; Madani R; Ahima RS; Drucker DJ; Stoffers DA
    Diabetes; 2003 Feb; 52(2):365-71. PubMed ID: 12540609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.